13D/G large-stake feed

Latest 13D/G Reports

Since 01 Aug 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G

Empery Asset Management, LP stake in Clene Inc.

Holder CIK 0001469336

13G CLNN
CIK
0001469336
Issuer
Clene Inc.
Security
CLNN
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
7.2% / 916,532 shares
Filed
04 Aug 2026, 10:08:38 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

Empery Asset Management, LP stake in Cellectar Biosciences, Inc.

Holder CIK 0001469336

13G CLRB
CIK
0001469336
Issuer
Cellectar Biosciences, Inc.
Security
CLRB
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
10% / 864,090 shares
Filed
04 Aug 2026, 10:06:05 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

Empery Asset Management, LP stake in Lantern Pharma Inc.

Holder CIK 0001469336

13G LTRN
CIK
0001469336
Issuer
Lantern Pharma Inc.
Security
LTRN
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
10% / 1,322,551 shares
Filed
04 Aug 2026, 10:03:38 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

BAILLIE GIFFORD & CO stake in Denali Therapeutics Inc.

Holder CIK 0001088875

13G/A DNLI
CIK
0001088875
Issuer
Denali Therapeutics Inc.
Security
DNLI
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
7.5% / 11,960,230 shares
Filed
04 Aug 2026, 09:11:07 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

BAILLIE GIFFORD & CO stake in Coursera, Inc.

Holder CIK 0001088875

13G/A COUR
CIK
0001088875
Issuer
Coursera, Inc.
Security
COUR
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5.4% / 15,409,837 shares
Filed
04 Aug 2026, 09:09:20 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

BAILLIE GIFFORD & CO stake in Coupang, Inc.

Holder CIK 0001088875

13G/A CPNG
CIK
0001088875
Issuer
Coupang, Inc.
Security
CPNG
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
4.8% / 78,743,687 shares
Filed
04 Aug 2026, 09:07:24 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
4,351-4,400 of 4,456
Per page
50
Current page
88

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

10%

Highest class ownership surfaced in the preview cards.

Newest evidence

04 Aug 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

Empery Asset Management, LP

Clene Inc. (CLNN)

Schedule 13G Ownership 7.2% Filing-backed
CIK
000091957426004749
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
7.2%
Filed
04 Aug 2026, 10:08:38 UTC
Period
30 Jun 2026

Empery Asset Management, LP filed Schedule 13G for Clene Inc. (CLNN). Reported class ownership: 7.2%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Empery Asset Management, LP

Cellectar Biosciences, Inc. (CLRB)

Schedule 13G Ownership 10% Filing-backed
CIK
000091957426004748
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
10%
Filed
04 Aug 2026, 10:06:05 UTC
Period
30 Jun 2026

Empery Asset Management, LP filed Schedule 13G for Cellectar Biosciences, Inc. (CLRB). Reported class ownership: 10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Empery Asset Management, LP

Lantern Pharma Inc. (LTRN)

Schedule 13G Ownership 10% Filing-backed
CIK
000091957426004747
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
10%
Filed
04 Aug 2026, 10:03:38 UTC
Period
30 Jun 2026

Empery Asset Management, LP filed Schedule 13G for Lantern Pharma Inc. (LTRN). Reported class ownership: 10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

BAILLIE GIFFORD & CO

Denali Therapeutics Inc. (DNLI)

Schedule 13G/A Ownership 7.5% Filing-backed
CIK
000108887526000056
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
7.5%
Filed
04 Aug 2026, 09:11:07 UTC
Period
30 Jun 2026

BAILLIE GIFFORD & CO filed Schedule 13G/A for Denali Therapeutics Inc. (DNLI). Reported class ownership: 7.5%. Ownership change: -1.1%. Share change: -2.9%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

BAILLIE GIFFORD & CO

Coursera, Inc. (COUR)

Schedule 13G/A Ownership 5.4% Filing-backed
CIK
000108887526000055
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
5.4%
Filed
04 Aug 2026, 09:09:20 UTC
Period
30 Jun 2026

BAILLIE GIFFORD & CO filed Schedule 13G/A for Coursera, Inc. (COUR). Reported class ownership: 5.4%. Ownership change: -3.4%. Share change: +5.6%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

BAILLIE GIFFORD & CO

Coupang, Inc. (CPNG)

Schedule 13G/A Ownership 4.8% Filing-backed
CIK
000108887526000054
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
4.8%
Filed
04 Aug 2026, 09:07:24 UTC
Period
30 Jun 2026

BAILLIE GIFFORD & CO filed Schedule 13G/A for Coupang, Inc. (CPNG). Reported class ownership: 4.8%. Ownership change: -2.4%. Share change: -35%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
Empery Asset Management, LP CIK 0001469336 CLNN Clene Inc. 916,532 7.2% SEC filing
Empery Asset Management, LP CIK 0001469336 CLRB Cellectar Biosciences, Inc. 864,090 10% SEC filing
Empery Asset Management, LP CIK 0001469336 LTRN Lantern Pharma Inc. 1,322,551 10% SEC filing
BAILLIE GIFFORD & CO CIK 0001088875 DNLI Denali Therapeutics Inc. 11,960,230 7.5% SEC filing
BAILLIE GIFFORD & CO CIK 0001088875 COUR Coursera, Inc. 15,409,837 5.4% SEC filing
BAILLIE GIFFORD & CO CIK 0001088875 CPNG Coupang, Inc. 78,743,687 4.8% SEC filing
BAILLIE GIFFORD & CO CIK 0001088875 ELF e.l.f. Beauty, Inc. 7,048,752 12% SEC filing
RIVER GLOBAL INVESTORS LLP CIK 0001486180 MXCT MAXCYTE, INC. 834,100 0.8% SEC filing
FARALLON CAPITAL MANAGEMENT, L.L.C. CIK 0000909661 LQDA Liquidia Corporation 8,365,038 9.4% SEC filing
Uihlein Richard E CIK 0001694903 GALT GALECTIN THERAPEUTICS INC 54,673,646 49% SEC filing
FARALLON CAPITAL MANAGEMENT, L.L.C. CIK 0000909661 ASMB Assembly Biosciences, Inc. 1,604,590 8.1% SEC filing
Chernett Jorey CIK 0002042077 STIM Neuronetics, Inc. 10,588,988 15% SEC filing
ZHANG PINGTING CIK 0002118826 STFS Star Fashion Culture Holdings Limited 0 0% SEC filing
ZHANG PINGTING CIK 0002118826 STFS Star Fashion Culture Holdings Limited 0 0% SEC filing
Hub Cyber Security Ltd. CIK 0001905660 EVFM Evofem Biosciences, Inc. 14,709,204 10% SEC filing
Chen Xiangdong CIK 0001798421 GOTU Gaotu Techedu Inc. 82,119,817 52% SEC filing
Huang Ximing CIK 0002133079 SEII SHARING ECONOMY INTERNATIONAL INC. 4,103,939,641 66% SEC filing
Chen Johnny CIK 0002136079 SEII SHARING ECONOMY INTERNATIONAL INC. 724,224,643 12% SEC filing
Catalyst4, Inc. CIK 0001900201 MPLT MapLight Therapeutics, Inc. 20,906,689 48% SEC filing
BLUHM NEIL CIK 0001373161 RSI Rush Street Interactive, Inc. 100,085,274 46% SEC filing
Saba Capital Management, L.P. CIK 0001510281 ECAT BlackRock ESG Capital Allocation Term Trust 15,798,219 16% SEC filing
Saba Capital Management, L.P. CIK 0001510281 BPRE Bluerock Private Real Estate Fund 7,201,382 5% SEC filing
INTEGRATED CORE STRATEGIES (US) LLC CIK 0001319244 AMAN Amanat Acquisition Corp 276,160 3.5% SEC filing
Saba Capital Management, L.P. CIK 0001510281 ASA ASA Gold and Precious Metals Limited 5,903,701 32% SEC filing
BANK OF AMERICA CORP /DE/ CIK 0000070858 SWZ Total Return Securities Fund 869,185 6.7% SEC filing
INTEGRATED CORE STRATEGIES (US) LLC CIK 0001319244 RVPH Reviva Pharmaceuticals Holdings, Inc. 1,072,690 8.2% SEC filing
Mansueto Daniel CIK 0002047675 MORN Morningstar, Inc. 3,752,046 10% SEC filing
Market Technology Acquisition Sponsor LLC CIK 0002143055 CUSIP G58A7W104 Market Technology Acquisition Corp 7,285,833 26% SEC filing
Wilson Dennis J. CIK 0001407029 LULU lululemon athletica inc. 9,576,564 8.4% SEC filing
Simmons Chia-Lin CIK 0001868194 LGMK LogicMark, Inc. 74,965 8.3% SEC filing
Radoff Bradley Louis CIK 0001380585 GCO GENESCO INC 535,000 4.8% SEC filing
J.H. Whitney VII, L.P. CIK 0001483044 AVAH Aveanna Healthcare Holdings Inc. 15,523,810 7.1% SEC filing
CK Life Sciences Intl (Holdings) Inc CIK 0001297567 RNAZ TransCode Therapeutics, Inc. 14,134,481 84% SEC filing
RA CAPITAL MANAGEMENT, L.P. CIK 0001346824 CUSIP 811033109 Scribe Therapeutics Inc. 1,802,178 9.6% SEC filing
RA CAPITAL MANAGEMENT, L.P. CIK 0001346824 CAPR Capricor Therapeutics, Inc. 3,014,183 5.2% SEC filing
Linden Capital L.P. CIK 0001349339 WLII Willow Lane Acquisition Corp. II 1,034,343 6.9% SEC filing
FE IV OR Aggregator, LLC CIK 0002049291 BNZI Banzai International, Inc. 61,331 2.9% SEC filing
Linden Capital L.P. CIK 0001349339 CUSIP G58A7W120 Market Technology Acquisition Corp 1,275,000 6% SEC filing
Linden Capital L.P. CIK 0001349339 CUSIP G1955J120 Catalyst Acquisition Corp. 1,300,000 6.4% SEC filing
Boston Partners CIK 0001386060 FTDR Frontdoor, Inc. 5,185,474 7.4% SEC filing
BANK OF AMERICA CORP /DE/ CIK 0000070858 FSP FRANKLIN STREET PROPERTIES CORP /MA/ 5,433,645 5.2% SEC filing
UBS Group AG CIK 0001610520 ACPPRA abrdn Income Credit Strategies Fund 480,458 30% SEC filing
Earl Thomas CIK 0002050375 VG Venture Global, Inc. 22,882,152 4.3% SEC filing
BANK OF AMERICA CORP /DE/ CIK 0000070858 RACC Research Alliance Corp III 503,914 6.5% SEC filing
Larson Keith D CIK 0002050857 VG Venture Global, Inc. 24,628,692 4.6% SEC filing
Thayer Jonathan W CIK 0001448765 VG Venture Global, Inc. 23,264,349 4.4% SEC filing
BANK OF AMERICA CORP /DE/ CIK 0000070858 BTZ BLACKROCK CREDIT ALLOCATION INCOME TRUST 4,799,384 5.1% SEC filing
BIGGER CAPITAL FUND L P CIK 0001288478 NRXS Neuraxis, INC 831,729 6.7% SEC filing
WASATCH ADVISORS LP CIK 0000814133 PAY Paymentus Holdings Inc 8,653,092 14% SEC filing
Alta Partners LLC CIK 0001896206 CISS C3is Inc. 1,168,303 8.2% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .